(Q51822756)

13 April 2018

title

Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma. (English)

1 reference

13 April 2018

author name string

Kazuhiro Nouso

1

1 reference

13 April 2018

Kazuya Kariyama

2

1 reference

13 April 2018

Shinichiro Nakamura

3

1 reference

13 April 2018

Ayano Oonishi

4

1 reference

13 April 2018

Akiko Wakuta

5

1 reference

13 April 2018

Atsushi Oyama

6

1 reference

13 April 2018

Soichiro Ako

7

1 reference

13 April 2018

Chihiro Dohi

8

1 reference

13 April 2018

Nozomu Wada

9

1 reference

13 April 2018

Yuki Morimoto

10

1 reference

13 April 2018

Yasuto Takeuchi

11

1 reference

13 April 2018

Kenji Kuwaki

12

1 reference

13 April 2018

Hideki Onishi

13

1 reference

13 April 2018

Fusao Ikeda

14

1 reference

13 April 2018

Hidenori Shiraha

15

1 reference

13 April 2018

Akinobu Takaki

16

1 reference

13 April 2018

Hiroyuki Okada

17

1 reference

13 April 2018

publication date

6 September 2016

1 reference

13 April 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

13 April 2018

volume

32

1 reference

13 April 2018

page(s)

695-700

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

Epidemiology of viral hepatitis and hepatocellular carcinoma

cites work

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

21 January 2018

1 reference

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

21 January 2018

1 reference

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

21 January 2018

1 reference

Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma

21 January 2018

1 reference

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

21 January 2018

1 reference

Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma

21 January 2018

1 reference

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

21 January 2018

1 reference

Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma

21 January 2018

1 reference

Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma

21 January 2018

1 reference

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

21 January 2018

1 reference

Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.

21 January 2018

1 reference

A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use.

21 January 2018

1 reference

Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13586

1 reference

13 April 2018

PubMed ID

27597181

1 reference

13 April 2018